CAS: 216974-75-3 - Bevacizumab
Formula:C6638H1016N1720O2108S44
- Synonyms:
- Bevacizumab
- Avastin
USP mAb 002, Monoclonal IgG1
CAS:216974-75-3
Immunological products, unmixed, not put up in measured doses or in forms or packings for …
Color and Shape:
Colorless Yellow Brown Liquid
Molecular weight:
203.09061
Estimated delivery in United States, on Tuesday 7 Jan 2025
Bevacizumab
CAS:216974-75-3
Ipilimumab targets CTLA-4, an immune checkpoint inhibitor. Bevacizumab binds to VEGF-A isoforms.
Purity:
95.4% (SEC-HPLC) - CE-SDS:97.5% SEC-HPLC:98.0%
Color and Shape:
Liquid
Molecular weight:
146.53 kDa
Ref: TM-T9904
| 1mg | 127.00 € | ||
| 2mg | 202.00 € | ||
| 5mg | 374.00 € | ||
| 10mg | 557.00 € | ||
| 25mg | 891.00 € | ||
| 50mg | 1,209.00 € | ||
| 100mg | 1,625.00 € | ||
| 200mg | 2,201.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Bevacizumab (Avastin)
CAS:216974-75-3
Formula:
C6638H1016N1720O2108S44
Color and Shape:
White To Off-White Solid
Molecular weight:
149196.82
Ref: 4Z-B-128001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Bevacizumab - 25mg/ml solution in PBS
CAS:216974-75-3
Monoclonal antibody against VEGF
Formula:
C6638H1016N1720O2108S44
Purity:
Min. 94 Area-%
Color and Shape:
Clear Liquid
Molecular weight:
149196.93
Ref: 3D-FB76708
| 1mg | 340.00 € | ||
| 2mg | 426.00 € | ||
| 5mg | 738.00 € | ||
| 10mg | 1,235.00 € | ||
| 25mg | 3,009.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
